Doctor Gets First U.S. Lung-Liver Transplant for Advanced Lung Cancer - HealthDay
HealthDay
by
2h ago
Doctor Gets First U.S. Lung-Liver Transplant for Advanced Lung Cancer  HealthDay ..read more
Visit website
Study explores the future of at-home cancer treatment - EurekAlert
EurekAlert
by
2h ago
Study explores the future of at-home cancer treatment  EurekAlert ..read more
Visit website
Northwest Health – Porter Launches Robotic-Assisted Lung Biopsy Surgery for Early Detection of Lung Cancer: The ... - Portage.Life
Portage.Life
by
2h ago
Northwest Health – Porter Launches Robotic-Assisted Lung Biopsy Surgery for Early Detection of Lung Cancer: The ...  Portage.Life ..read more
Visit website
Revolutionizing Cancer Care With Genomic Testing - Targeted Oncology
Targeted Oncology
by
2h ago
Revolutionizing Cancer Care With Genomic Testing  Targeted Oncology ..read more
Visit website
China's NMPA Accepts sNDA for Savolitinib in Locally Advanced/Metastatic MET Exon 14+ NSCLC - OncLive
OncLive
by
2h ago
China's NMPA Accepts sNDA for Savolitinib in Locally Advanced/Metastatic MET Exon 14+ NSCLC  OncLive ..read more
Visit website
Wearable Activity Tracker Data Enhance Patient Assessment in Lung Cancer - AJMC.com Managed Markets Network
AJMC.com Managed Markets Network
by
2h ago
Wearable Activity Tracker Data Enhance Patient Assessment in Lung Cancer  AJMC.com Managed Markets Network ..read more
Visit website
EU Approves Merck’s Keytruda, Chemo Combo for Lung Cancer - BioSpace
BioSpace
by
2h ago
EU Approves Merck’s Keytruda, Chemo Combo for Lung Cancer  BioSpace ..read more
Visit website
Perioperative Pembrolizumab Wins Approval in Europe for Resectable NSCLC at High Risk of Recurrence - OncLive
OncLive
by
2h ago
Perioperative Pembrolizumab Wins Approval in Europe for Resectable NSCLC at High Risk of Recurrence  OncLive ..read more
Visit website
European Commission Approves Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant ... - The Bakersfield Californian
The Bakersfield Californian
by
2h ago
European Commission Approves Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant ...  The Bakersfield Californian ..read more
Visit website
Guidelines Webinar - Non-Oncogene-Addicted mNSCLC 2024 - OncologyPRO
OncologyPRO
by
2h ago
Guidelines Webinar - Non-Oncogene-Addicted mNSCLC 2024  OncologyPRO ..read more
Visit website

Follow Lung cancer - Google News on FeedSpot

Continue with Google
Continue with Apple
OR